Knockdown of Gene A, upregulated by mutant KRAS, inhibits growth of lung cancer in part through upregulating p21

被引:0
|
作者
Kawabe, Nozomi [1 ]
Muraki, Nao [1 ]
Umeda, Kanna [1 ]
Komeda, Kazuki [2 ]
Ohashi, Ayano [1 ]
Katsuda, Masahito [1 ]
Tomatsu, Aya [1 ]
Yoshida, Mikina [1 ]
Iwabe, Ayana [1 ]
Sunaga, Noriaki [3 ]
Taguchi, Ayumu [4 ]
John, Minna [5 ]
Tanaka, Ichidai [2 ]
Matsushima, Miyoko [1 ]
Kawabe, Tsutomu [1 ]
Sato, Mitsuo [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Integrated Hlth Sci, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan
[3] Gunma Univ, Grad Sch Med, Dept Resp Med, Maebashi, Gumma, Japan
[4] Aichi Canc Ctr, Res Inst, Div Mol Diagnost, Nagoya, Aichi, Japan
[5] Univ Texas Southwestern Med Ctr, Dallas, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-2064
引用
收藏
页码:903 / 903
页数:1
相关论文
共 50 条
  • [21] P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth
    He, Hong
    Nhi Huynh
    Liu, Kevin H.
    Malcontenti-Wilson, Cathy
    Zhu, Jin
    Christophi, Christopher
    Shulkes, Arthur
    Baldwin, Graham S.
    CANCER LETTERS, 2012, 317 (01) : 65 - 71
  • [22] Licofelone inhibits NNK-induced lung adenocarcinoma formation in A/J mice by suppressing COX/LOX and inhibits human lung cancer cell growth by p21 up-regulation.
    Patlolla, Jagan Mohan Reddy
    Kopelovich, Levy
    Qian, Li
    Biddick, Laura
    Zhang, Yuting
    Desai, Dhimant
    Amin, Shantu
    Lightfoot, Stan
    Rao, Chinthalapally V.
    CANCER RESEARCH, 2013, 73 (08)
  • [23] The BET bromodomain inhibitor JQ1 radiosensitizes non-small cell lung cancer cells by upregulating p21
    Wang, Jian
    Wang, Ye
    Mei, Hong
    Yin, Zhongyuan
    Geng, Yuanyuan
    Zhang, Tao
    Wu, Gang
    Lin, Zhenyu
    CANCER LETTERS, 2017, 391 : 141 - 151
  • [24] HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway
    Huang, Hao
    Han, Yong
    Yang, Xingjiu
    Li, Mengyuan
    Zhu, Ruimin
    Hu, Juanjuan
    Zhang, Xiaowei
    Wei, Rongfei
    Li, Kejuan
    Gao, Ran
    ONCOTARGET, 2017, 8 (61) : 103364 - 103374
  • [25] c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression
    Morrison, Chevaun D.
    Allington, Tressa M.
    Thompson, Cheryl L.
    Gilmore, Hannah L.
    Chang, Jenny C.
    Keri, Ruth A.
    Schiemann, William P.
    ONCOTARGET, 2016, 7 (45) : 72777 - 72794
  • [26] Curcumin inhibits growth of ovarian cancer cells via Egr1-dependent p21 induction
    Song, Haengseok
    Lee, Jae Eun
    Choi, Ji Young
    Hong, Jae Sik
    Hahn, Ho Suap
    Yoon, Seok Geun
    Kwon, Yong Soon
    Lee, In Ho
    Lim, Kyung Taek
    Lee, Ki Heon
    Shim, Jae Uk
    Mok, Jung Eun
    Kim, Tae Jin
    CANCER RESEARCH, 2009, 69
  • [27] NVP-BEZ235 inhibits thyroid cancer growth by p53-dependent/independent p21 upregulation
    Ruan, Banjun
    Liu, Wei
    Chen, Pu
    Cui, Rongrong
    Li, Yu
    Ji, Meiju
    Hou, Peng
    Yang, Qi
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (04): : 682 - 693
  • [28] Combination of liquiritin, isoliquiritin and isoliquirigenin induce apoptotic cell death through upregulating p53 and p21 in the A549 non-small cell lung cancer cells
    Zhou, Yanling
    Ho, Wing Shing
    ONCOLOGY REPORTS, 2014, 31 (01) : 298 - 304
  • [29] FGF inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-cdk2.
    Aikawa, T
    Segre, GV
    Lee, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S188 - S188
  • [30] IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL
    Fang, Yujiang
    Chen, Xuhui
    Bai, Qian
    Qin, Chenglu
    Mohamud, Abdimalik O.
    Zhu, Ziwen
    Ball, Tyler W.
    Ruth, Caleb M.
    Newcomer, Dylan R.
    Herrick, Elizabeth J.
    Nicholl, Michael B.
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (08) : 969 - 974